Immunization with tumor‐derived ER chaperone grp170 elicits tumor‐specific CD8+ T‐cell responses and reduces pulmonary metastatic disease

Glucose‐regulated protein (grp) 170 is a molecular chaperone localized in endoplasmic reticulum (ER), which has been demonstrated to interact with the peptides translocated by transporter associated with antigen presentation (TAP). In our study, we have evaluated the therapeutic efficacy of tumor‐derived grp170 against the highly metastatic and poorly immunogenic murine melanoma B16F10. Immunization of mice with grp170 preparations from autologous tumor significantly delayed progression of the primary cancer and reduced established pulmonary metastases, which was associated with the prolonged survival of metastases‐bearing mice. However, grp170 from normal liver or antigenically distinct tumor failed to exhibit therapeutic effect. In addition, tumor‐derived grp170 elicited a potent cytotoxic T‐lymphocyte response specific for B16F10 tumor, which correlates with in vivo protective effects. Adoptive transfer of splenocytes obtained from B16F10‐grp170‐primed animals remarkably suppressed pulmonary metastases. Depletion of either CD4+ or CD8+ T cells in priming phase significantly abrogated the tumor immunity induced by the B16F10‐grp170. However, the vaccine activity was intact when CD4+, not CD8+, T cells were depleted in effector phase. It suggests that CD4+ T helper cells play an important role in the generation of effective antitumor response, whereas CD8+ T cells are predominantly involved in direct killing of tumor cells. These observations have strong clinical implications for using tumor‐derived grp170 as a therapeutic vaccine against metastatic diseases. © 2003 Wiley‐Liss, Inc.

[1]  C. Nicchitta,et al.  Transfer of GRP94(Gp96)‐Associated Peptides onto Endosomal MHC Class I Molecules , 2002, Traffic.

[2]  Y. Tamura,et al.  Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. , 2001, Blood.

[3]  E. Repasky,et al.  Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity1 , 2001, The Journal of Immunology.

[4]  P. Srivastava Immunotherapy of human cancer: lessons from mice , 2000, Nature Immunology.

[5]  Jonathan J. Lewis,et al.  Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study , 2000, International journal of cancer.

[6]  Yoshiyuki Kaneko,et al.  The Hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s , 2000, Cell stress & chaperones.

[7]  P. Srivastava,et al.  CD91: a receptor for heat shock protein gp96 , 2000, Nature Immunology.

[8]  B. Bodey,et al.  Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. , 2000, Anticancer research.

[9]  H. Rammensee,et al.  The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor , 2000, European journal of immunology.

[10]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[11]  A. Melcher,et al.  Heat shock proteins refine the danger theory , 2000, Immunology.

[12]  R. Young,et al.  A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. , 2000, Immunity.

[13]  T. Wu,et al.  Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. , 2000, Cancer research.

[14]  J. Neefjes,et al.  Identification of novel peptide binding proteins in the endoplasmic reticulum: ERp72, calnexin, and grp170. , 1999, Biochemistry.

[15]  H. Rammensee,et al.  Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. , 1999, Journal of immunology.

[16]  Ferry Ossendorp,et al.  CD4 T Cells and Their Role in Antitumor Immune Responses , 1999, The Journal of experimental medicine.

[17]  P. Srivastava,et al.  Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. , 1997, Science.

[18]  T. Dierks,et al.  A microsomal ATP‐binding protein involved in efficient protein transport into the mammalian endoplasmic reticulum. , 1996, The EMBO journal.

[19]  H. Lin,et al.  The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin. , 1993, Molecular biology of the cell.

[20]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[21]  E. Appella,et al.  A mouse tumor-specific transplantation antigen is a heat shock-related protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  I. Fidler,et al.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.